Dosimetry using Lu-177 DOTATATE, Lu-177 HA-DOTATATE and Lu-177 DOTATOC: Comparative Results in Patients Undergoing Peptide Receptor Radionuclide Therapy (PRRT)

被引：0
|
作者：
Schuchardt, C. [1 ]
Kulkarni, H. R. [1 ]
Wiessalla, S. [1 ]
Shahinfar, M. [1 ]
Shafaei, S. [1 ]
Kropf, S. [2 ]
Wester, H. J. [3 ,4 ]
Baum, R. P. [1 ]
机构：
[1] Zent Klin Bad Berka GmbH, THERANOST Ctr Mol Radiotherapy & Mol Imaging, Bad Berka, Germany
[2] Scintomics GmbH, Fuerstenfeldbruck, Germany
[3] Tech Univ Munich, Fac Chem, D-80290 Munich, Germany
[4] Tech Univ Munich, Fac Med, D-80290 Munich, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP291
引用
收藏
页码：S224 / S225
页数：2
相关论文
共 50 条
  • [41] Comparative evaluation of carrier added and non carrier added Lu-177 for preparation of therapeutic doses of Lu-177 radiopharmaceuticals
    Bhusari, P.
    Shukla, J.
    Singh, H.
    Sood, A.
    Mittal, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S688 - S688
  • [42] The SNMMI Lu-177 Dosimetry Global Challenge: Results and Conclusions
    Dewaraja, Yuni
    Danieli, R.
    Erwin, W.
    Uribe, C.
    MEDICAL PHYSICS, 2022, 49 (06) : E450 - E451
  • [43] Occupational and ambient radiation exposures from Lu-177 DOTATATE during targeted therapy
    Sulieman, A.
    Mayhoub, Fareed H.
    Salah, Hassan
    Al-Mohammed, H., I
    Alkhorayef, M.
    Moftah, B.
    Al Rowaily, M.
    Bradley, D. A.
    APPLIED RADIATION AND ISOTOPES, 2020, 164
  • [44] ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy
    Love, Charito
    Desai, Neil B.
    Abraham, Tony
    Banks, Kevin P.
    Bodei, Lisa
    Boike, Thomas
    Brown, Richard K. J.
    Bushnell, David L.
    DeBlanche, Lorraine E.
    Dominello, Michael M.
    Francis, Tony
    Grady, Erin C.
    Hobbs, Robert F.
    Hope, Thomas A.
    Kempf, Jeffrey S.
    Pryma, Daniel A.
    Rule, William
    Savir-Baruch, Bital
    Sethi, Ila
    Subramaniam, Rathan M.
    Xiao, Ying
    Schechter, Naomi R.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (06): : 233 - 242
  • [45] ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy
    Love, Charito
    Desai, Neil B.
    Abraham, Tony
    Banks, Kevin P.
    Bodei, Lisa
    Boike, Thomas
    Brown, Richard K. J.
    Bushnell, David L.
    DeBlanche, Lorraine E.
    Dominello, Michael M.
    Francis, Tony
    Grady, Erin C.
    Hobbs, Robert F.
    Hope, Thomas A.
    Kempf, Jeffrey S.
    Pryma, Daniel A.
    Rule, William
    Savir-Baruch, Bital
    Sethi, Ila
    Subramaniam, Rathan M.
    Xiao, Ying
    Schechter, Naomi R.
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (06) : 503 - 511
  • [46] Towards a quality assurance for dosimetry in peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE
    Marin, G.
    Vanderlinden, B.
    Wimana, Z.
    Guiot, T.
    Karfis, I.
    Flamen, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S159 - S160
  • [47] Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE; dosimetric findings
    Mok, S.
    Tay, Y.
    Ng, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S532 - S532
  • [48] Evaluation of infusion pump delivery system for LUTATHERA® (lutetium Lu-177 dotatate).
    Doherty, Kathryn
    Houston, Tim
    Kowalczyk, Steven
    Gruchot, Michelle
    Dillehay, Gary
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [49] INDIVIDUAL VARIATION IN RENAL DOSIMETRY OF Lu-177 OCTREOTATE
    McKay, Erin
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 8 - 8
  • [50] Failure Modes and Effects Analysis with Lu-177 Dotatate PRRT in a Radiation Oncology-based Program
    Maughan, N.
    Kim, H.
    Roach, M.
    Garcia-Ramirez, J.
    Amurao, M.
    Hao, Y.
    Zoberi, J.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S986 - S986
12345